Cargando…

Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis

Background: The glomerular endothelial glycocalyx is degraded during inflammation. The glycocalyx plays a pivotal role in endothelial function and is involved in many processes including binding of chemokines and cytokines, leukocyte trafficking, and preventing proteinuria. HS-based therapeutics are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buijsers, Baranca, Maciej-Hulme, Marissa, Jacobs, Maaike, Bebber, Marinka Bakker-van, de Graaf, Mark, Salmenov, Rustem, Parr, Naomi, Rabelink, Ton J., Nijenhuis, Tom, van der Vlag, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354240/ https://www.ncbi.nlm.nih.gov/pubmed/37475889 http://dx.doi.org/10.3389/fmolb.2023.1223972

Ejemplares similares

Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy
por: Buijsers, Baranca, et al.
Publicado: (2023)

Glomerular endothelial glycocalyx-derived heparan sulfate inhibits glomerular leukocyte influx and attenuates experimental glomerulonephritis
por: Maciej-Hulme, Marissa L., et al.
Publicado: (2023)

Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
por: Buijsers, Baranca, et al.
Publicado: (2020)

Heparanase Is a Putative Mediator of Endothelial Glycocalyx Damage in COVID-19 – A Proof-of-Concept Study
por: Drost, Carolin Christina, et al.
Publicado: (2022)

RNA Contaminates Glycosaminoglycans Extracted from Cells and Tissues
por: van Gemst, Jasper J., et al.
Publicado: (2016)

Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuria
por: Garsen, Marjolein, et al.
Publicado: (2023)

Increased Plasma Heparanase Activity in COVID-19 Patients
por: Buijsers, Baranca, et al.
Publicado: (2020)

Glycosaminoglycan-Protein Interactions and Their Roles in Human Disease
por: Shi, Deling, et al.
Publicado: (2021)

NMR Characterization of the Interactions Between Glycosaminoglycans and Proteins
por: Bu, Changkai, et al.
Publicado: (2021)

Blocking of inflammatory heparan sulfate domains by specific antibodies is not protective in experimental glomerulonephritis
por: van Gemst, Jasper J., et al.
Publicado: (2021)

Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies
por: Loeven, Markus A., et al.
Publicado: (2021)

Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury
por: Maicas, Nuria, et al.
Publicado: (2017)

Primary Focal Segmental Glomerulosclerosis Plasmas Increase Lipid Droplet Formation and Perilipin-2 Expression in Human Podocytes
por: den Braanker, Dirk J. W., et al.
Publicado: (2022)

Dynamic Expression of Genes Involved in Proteoglycan/Glycosaminoglycan Metabolism during Skin Development
por: Uijtdewilligen, P. J. E., et al.
Publicado: (2018)

Heparan sulfate mimetic fucoidan restores the endothelial glycocalyx and protects against dysfunction induced by serum of COVID-19 patients in the intensive care unit
por: Yuan, Lushun, et al.
Publicado: (2022)

Increased Plasma Heparanase Activity and Endothelial Glycocalyx Degradation in Dengue Patients Is Associated With Plasma Leakage
por: Buijsers, Baranca, et al.
Publicado: (2021)

Role of syndecan-1 in the interaction between dendritic cells and T cells
por: Kouwenberg, M., et al.
Publicado: (2020)

Novel mouse strains to study circulating permeability factor(s) in primary focal segmental glomerulosclerosis
por: den Braanker, Dirk, et al.
Publicado: (2022)

Minimal Change Disease: More Than a Podocytopathy?
por: Maas, Rutger J., et al.
Publicado: (2022)

Laminar flow substantially affects the morphology and functional phenotype of glomerular endothelial cells
por: ‘t Hart, Daan C., et al.
Publicado: (2021)

A Putative Role for TRPC6 in Immune-Mediated Kidney Injury
por: ‘t Hart, Daan C., et al.
Publicado: (2023)

Inhibition of mTOR delayed but could not prevent experimental collapsing focal segmental glomerulosclerosis
por: Miesen, Laura, et al.
Publicado: (2020)

Repurposing Riociguat to Target a Novel Paracrine Nitric Oxide-TRPC6 Pathway to Prevent Podocyte Injury
por: ‘t Hart, Daan, et al.
Publicado: (2021)

Glycosaminoglycans and Glycosaminoglycan Mimetics in Cancer and Inflammation
por: Morla, Shravan
Publicado: (2019)

Direct Observation of Enhanced Nitric Oxide in a Murine Model of Diabetic Nephropathy
por: Boels, Margien G. S., et al.
Publicado: (2017)

Functional Characterization of PALB2 Variants of Uncertain Significance: Toward Cancer Risk and Therapy Response Prediction
por: Boonen, Rick A. C. M., et al.
Publicado: (2020)

Endothelial Nitric Oxide Synthase Prevents Heparanase Induction and the Development of Proteinuria
por: Garsen, Marjolein, et al.
Publicado: (2016)

Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons
por: Rother, Nils, et al.
Publicado: (2020)

Ligation of α-Dystroglycan on Podocytes Induces Intracellular Signaling: A New Mechanism for Podocyte Effacement?
por: Vogtländer, Nils P. J., et al.
Publicado: (2009)

Fucoidans in Nanomedicine
por: Chollet, Lucas, et al.
Publicado: (2016)

Human Sulfotransferase Assays With PAPS Production in situ
por: Sun, Yanan, et al.
Publicado: (2022)

Are Helicobacter pylori Infection and Fucoidan Consumption Associated with Fucoidan Absorption?
por: Tomori, Makoto, et al.
Publicado: (2020)

Glycosaminoglycans Metabolism
por: Viola, Manuela, et al.
Publicado: (2012)

Chemokines and Glycosaminoglycans
por: Proudfoot, Amanda E. I.
Publicado: (2015)

Glycosaminoglycans and Proteoglycans
por: Pomin, Vitor H., et al.
Publicado: (2018)

Glycosaminoglycans and Their Mimetics
por: Ferro, Vito
Publicado: (2016)

Reduced CXCL1 production by endogenous IL-37 expressing dendritic cells does not affect T cell activation
por: Kouwenberg, M., et al.
Publicado: (2021)

Fucoidan: Structure and Bioactivity
por: Li, Bo, et al.
Publicado: (2008)

Fucoidans and Bowel Health
por: Yang, Jin-Young, et al.
Publicado: (2021)

Microvascular differences in individuals with obesity at risk of developing cardiovascular disease
por: van der Velden, Anouk I. M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vfv6qfibsah9qtii8u3ljk0l0v